Funding Our DIPG Research Efforts

Federal grant money is scarce for “rare pediatric” diseases. Our progress in understanding DIPG has been funded primarily by private foundations, including:

Thanks to generous philanthropic support, Javad Nazarian, PhD and a multidisciplinary team of experts at Children's National have been involved in generating the complete protein profile of CSF from children with brain tumors.  And, a recent grant from the Rally Foundation will enable Dr. Nazarian and his team to study potential DIPG treatments in mouse models.

At the same time, we’re also hoping to secure a three-year grant that will enable our DIPG research team to:

  1. Create cells and avatar murine models that represent unique genomic subtypes
  2. Apply liquid biopsy to measure tumor response to treatment
  3. Conduct proteogenomic studies
  4. Test novel therapeutics
  5. Share our findings and advance the entire field of neuro-oncology

We believe the DIPG-focused team at Children’s Research Institute is poised to bring novel solutions, and ultimately improved outcomes, to DIPG patients around the world.